|
| 33222113 | Evaluation of Adherence and Persistence Differences Between Adalimumab Citrate-Free and Citrate Formulations for Patients with Immune-Mediated Diseases in the United States. | Rheumatol Ther | 2021 |
| 33024121 | Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study. | Nat Commun | 2020 |
| 26705579 | Relationship of hospital-associated bleeding with length of stay and total hospitalization costs in patients hospitalized for atrial fibrillation. | J Med Econ | 2016 |
| 24108232 | Comparison of Medical Costs of Patients With Atrial Fibrillation Unsuitable for Warfarin Treatment With Apixaban or Aspirin Based on AVERROES Trial. | Clin Appl Thromb Hemost | 2015 |
| 26719716 | The impact of ribavirin on real-world adherence rates in hepatitis C patients treated with sofosbuvir plus simeprevir. | Clinicoecon Outcomes Res | 2015 |
| 26213178 | Comparison of hospital length of stay between hospitalized non-valvular atrial fibrillation patients treated with either apixaban or warfarin. | Hosp Pract (1995) | 2015 |
| 25502587 | Evaluation of medical costs avoided when new oral anticoagulants are used for extended treatment of venous thromboembolism based on clinical trial results. | J Thromb Thrombolysis | 2015 |
| 24477787 | Estimation of the impact of warfarin's time-in-therapeutic range on stroke and major bleeding rates and its influence on the medical cost avoidance associated with novel oral anticoagulant use-learnings from ARISTOTLE, ROCKET-AF, and RE-LY trials. | J Thromb Thrombolysis | 2014 |
| 25438725 | Reviewing a clinical decision aid for the selection of anticoagulation treatment in patients with nonvalvular atrial fibrillation: applications in a US managed care health plan database. | Clin Ther | 2014 |
| 25082605 | Depression monitoring and patient behavior in the Clinical Outcomes in MEasurement-Based Treatment (COMET) trial. | Psychiatr Serv | 2014 |
| 25078794 | Evaluation of medical costs associated with use of new oral anticoagulants compared with standard therapy among venous thromboembolism patients. | J Med Econ | 2014 |
| 23262644 | Dosing patterns of aripiprazole and quetiapine for adjunctive treatment of major depressive disorder (2006-2010). | Int Clin Psychopharmacol | 2013 |
| 25135394 | Medical Costs of Oral Anticoagulants vs Warfarin for Atrial Fibrillation Patients with Different Stroke Risks. | Cardiol Ther | 2013 |
| 23869941 | Medical costs in the US of clinical events associated with oral anticoagulant (OAC) use compared to warfarin among non-valvular atrial fibrillation patients â¿¥75 and <75 years of age, based on the ARISTOTLE, RE-LY, and ROCKET-AF trials. | J Med Econ | 2013 |
| 23867114 | Warfarin use and stroke risk among patients with nonvalvular atrial fibrillation in a large managed care population. | Clin Ther | 2013 |
| 21512188 | Using administrative claims data to estimate virologic failure rates among human immunodeficiency virus-infected patients with antiretroviral regimen switches. | Med Decis Making | 2012 |
| 24991334 | Medical care costs and hospitalization in patients with bipolar disorder treated with atypical antipsychotics. | Am Health Drug Benefits | 2012 |
| 22746356 | Why is warfarin underused for stroke prevention in atrial fibrillation? A detailed review of electronic medical records. | Curr Med Res Opin | 2012 |
| 22807244 | Clinical Outcomes in Measurement-based Treatment (Comet): a trial of depression monitoring and feedback to primary care physicians. | Depress Anxiety | 2012 |
| 22910806 | Exposure to potentially dangerous drug-drug interactions involving antipsychotics. | Psychiatr Serv | 2012 |
| 22449118 | Medical cost reductions associated with the usage of novel oral anticoagulants vs warfarin among atrial fibrillation patients, based on the RE-LY, ROCKET-AF, and ARISTOTLE trials. | J Med Econ | 2012 |
| 22435786 | Impact of cost-sharing on treatment augmentation in patients with depression. | Am J Manag Care | 2012 |
| 22550279 | Cost-effectiveness of adjunctive therapy with atypical antipsychotics for acute treatment of major depressive disorder. | Ann Pharmacother | 2012 |
| 22264654 | Effect of communicating depression severity on physician prescribing patterns: findings from the Clinical Outcomes in MEasurement-based Treatment (COMET) trial. | Gen Hosp Psychiatry | 2012 |
| 22406879 | Coronary artery bypass graft surgery in acute coronary syndrome: incidence, cost impact, and acute clopidogrel interruption. | Hosp Pract (1995) | 2012 |
| 21991926 | Association between second-generation antipsychotic medication half-life and hospitalization in the community treatment of adult schizophrenia. | J Med Econ | 2012 |
| 21214937 | One-year risk of psychiatric hospitalization and associated treatment costs in bipolar disorder treated with atypical antipsychotics: a retrospective claims database analysis. | BMC Psychiatry | 2011 |
| 21840058 | Intent-to-treat analysis of health care expenditures of patients treated with atypical antipsychotics as adjunctive therapy in depression. | Clin Ther | 2011 |
| 21881388 | Impact of dyspnea on medical utilization and affiliated costs in patients with acute coronary syndrome. | Hosp Pract (1995) | 2011 |
| 21954966 | Comparison of second-generation antipsychotic treatment on psychiatric hospitalization in Medicaid beneficiaries with bipolar disorder. | J Med Econ | 2011 |
| 21515328 | A real-world data analysis of dose effect of second-generation antipsychotic therapy on hemoglobin A1C level. | Prog Neuropsychopharmacol Biol Psychiatry | 2011 |
| 20469957 | Cost burden of treatment resistance in patients with depression. | Am J Manag Care | 2010 |
| 20822071 | Cost-sharing effects on adherence and persistence for second-generation antipsychotics in commercially insured patients. | Manag Care | 2010 |
| 19527195 | Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone. | J Med Econ | 2009 |
| 25126291 | Use pattern and off-label use of atypical antipsychotics in bipolar disorder, 1998-2002. | Am Health Drug Benefits | 2009 |
| 19752841 | A systematic review of augmentation strategies for patients with major depressive disorder. | Psychopharmacol Bull | 2009 |
| 19446157 | Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis. | Clin Ther | 2009 |
| 18387057 | Drug safety surveillance in China and other countries: a review and comparison. | Value Health | 2008 |
| 19450075 | Principal components analysis of drug expenditure and utilisation trends for major therapeutic classes in US Medicaid programmes. | J Med Econ | 2008 |
| 18794035 | Utilization, price, and spending trends for antidepressants in the US Medicaid Program. | Res Social Adm Pharm | 2008 |
| 17590868 | Lethal drug probe in China: the case of Xinfu clindamycin. | Pharmacoepidemiol Drug Saf | 2007 |
| 17937821 | Utilization and spending trends for antiretroviral medications in the U.S. Medicaid program from 1991 to 2005. | AIDS Res Ther | 2007 |